Treatment Results in Childhood AML, with Special Reference to the German Studies BFM-78 and BFM-83

The number of children with acute myelogenous leukemia (AML) who achieve remission and the number of long-term survivors have increased in the last 10 years owing to intensified chemotherapy and better supportive care. This report reviews nine pediatric studies, particularly the German AML studies BFM-78 and BFM-83.